共 84 条
Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia
被引:2
作者:
Fato, Bianca R.
[1
,2
]
de Alwis, Natasha
[1
,2
]
Beard, Sally
[1
,2
]
Binder, Natalie K.
[1
,2
]
Pritchard, Natasha
[2
]
Kaitu'u-Lino, Tu'uhevaha J.
[2
]
Bubb, Kristen J.
[3
,4
]
Hannan, Natalie J.
[1
,2
]
机构:
[1] Univ Melbourne, Therapeut Discovery & Vasc Funct Pregnancy Grp, Heidelberg, Vic, Australia
[2] Univ Melbourne, Mercy Hosp Women, Dept Obstet Gynecol & Newborn Hlth, Heidelberg, Vic, Australia
[3] Monash Univ, Biomed Discovery Inst, Dept Physiol, Clayton, Vic, Australia
[4] Monash Univ, Victorian Heart Inst, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia
基金:
澳大利亚研究理事会;
英国医学研究理事会;
关键词:
dilatation;
natriuretic peptide;
C-type;
preeclampsia;
pregnancy;
therapeutics;
NECROSIS-FACTOR-ALPHA;
NITRIC-OXIDE;
CESAREAN DELIVERY;
HYPERTENSIVE DISORDERS;
TYROSINE KINASE-1;
HUMAN CIRCULATION;
GENE-EXPRESSION;
PREGNANCY;
CNP;
SECRETION;
D O I:
10.1161/HYPERTENSIONAHA.124.22820
中图分类号:
R6 [外科学];
学科分类号:
1002 ;
100210 ;
摘要:
BACKGROUND:Preeclampsia is a serious condition of pregnancy, complicated by aberrant maternal vascular dysfunction. CNP (C-type natriuretic peptide) contributes to vascular homeostasis, acting through NPR-B (natriuretic peptide receptor-B) and NPR-C (natriuretic peptide receptor-C). CNP mitigates vascular dysfunction of arteries in nonpregnant cohorts; this study investigates whether CNP can dilate maternal arteries in ex vivo preeclampsia models.METHODS:Human omental arteries were dissected from fat biopsies collected during cesarean section. CNP, NPR-B, and NPR-C mRNA expression was assessed in arteries collected from pregnancies complicated by preeclampsia (n=6) and normotensive controls (n=11). Using wire myography, we investigated the effects of CNP on dilation of arteries from normotensive pregnancies. Arteries were preconstricted with either serum from patients with preeclampsia (n=6) or recombinant ET-1 (endothelin-1; vasoconstrictor elevated in preeclampsia; n=6) to model vasoconstriction associated with preeclampsia. Preconstricted arteries were treated with recombinant CNP (0.001-100 mu mol/L) or vehicle and vascular relaxation assessed. In further studies, arteries were preincubated with NPR-B (5 mu mol/L) and NPR-C (10 mu mol/L) antagonists before serum-induced constriction (n=4-5) to explore mechanistic signaling.RESULTS:CNP, NPR-B, and NPR-C mRNAs were not differentially expressed in omental arteries from preeclamptic pregnancies. CNP potently stimulated maternal artery vasorelaxation in our model of preeclampsia (using preeclamptic serum). Its vasodilatory actions were driven through the activation of NPR-B predominantly; antagonism of this receptor alone dampened CNP vasorelaxation. Interestingly, CNP did not reduce ET-1-driven omental artery constriction.CONCLUSIONS:Collectively, these data suggest that enhancing CNP signaling through NPR-B offers a potential therapeutic strategy to reduce systemic vascular constriction in preeclampsia.
引用
收藏
页码:1883 / 1894
页数:12
相关论文